These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 19074460
1. Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Rose FF, Mattis VB, Rindt H, Lorson CL. Hum Mol Genet; 2009 Mar 15; 18(6):997-1005. PubMed ID: 19074460 [Abstract] [Full Text] [Related]
2. Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy. Rindt H, Buckley DM, Vale SM, Krogman M, Rose FF, Garcia ML, Lorson CL. Neuromuscul Disord; 2012 Mar 15; 22(3):277-85. PubMed ID: 22079083 [Abstract] [Full Text] [Related]
3. The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy. Harris AW, Butchbach ME. Neuromuscul Disord; 2015 Sep 15; 25(9):699-705. PubMed ID: 26055638 [Abstract] [Full Text] [Related]
4. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. Bowerman M, Murray LM, Boyer JG, Anderson CL, Kothary R. BMC Med; 2012 Mar 07; 10():24. PubMed ID: 22397316 [Abstract] [Full Text] [Related]
14. Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy. Mattis VB, Butchbach ME, Lorson CL. J Neurosci Methods; 2008 Oct 30; 175(1):36-43. PubMed ID: 18771690 [Abstract] [Full Text] [Related]